SPRY
ARS PharmaceuticalsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
SPRY Profile
Ars Pharmaceuticals, Inc.
A clinical-stage biopharmaceutical company developing innovative treatments for severe allergic reactions
11682 El Camino Real, Suite 120, San Diego, California 92130
--
ARS Pharmaceuticals, Inc., was incorporated under the laws of the State of Delaware on January 4, 2016. The company is a biopharmaceutical company focused on developing novel, potentially best-in-class product candidates, neffy for the emergency treatment of type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an innovative absorption enhancer called Intravail that allows neffy to deliver injection-like epinephrine absorption in small doses, easy to carry, easy to use, fast to administer and reliable nasal sprays.
